Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by JohnnyUtah16on Mar 15, 2019 5:43pm
122 Views
Post# 29494049

RE:Goodman Asleep at the Wheel yet again

RE:Goodman Asleep at the Wheel yet againMan, why are the majority of you stockhouse clowns so annoying. Why did you buy GUD if you were looking to make quick money. Goodman has been crystal clear from day 1 that he was going to play this slow and steady, waiting for the right opportunity so he can strategically build GUD into a world leading pharma company. Are you really suggesting that he should be listening to the idiots at Medison. If you invested in GUD you knew it was a "bet on the jockey" play, you were betting on Goodman and his ability to acquire the right companies. Yet, now you think they should do a 180 and take guidance from this nobody at Medison who says he can boost the revenue by 46% in 6 years. His presentation is completely misleading and doesn't show you the important fundamentals from a company that he is touting as his success story. Show us the declining income instead of growing revenues, oh yeah that wouldn't fit his narrative because people would see the company is losing more and more money. You want GUD to be another Concordia?

If you invested in GUD for a short term return you are an idiot and clearly dont research companies before you buy them. If you think Goodman the guy we all invested in should listen to this nobody and implement his make believe strategy for GUD to make boat loads of money than just sell your shares because you are invested in the wrong company. For the rest of us we will wait as long as it takes for the right opportunities to come up and Goodman to do what he does best. 
Bullboard Posts